The condition more associated with older age

Patient with FEV1 = 75%, CAT score of 12, with no exacerbations over the past 12 months

These two drug classes are first-line options in Patient Group A

When these two categories of medications are used concurrently, there is increased risk of adverse events with no therapeutic benefit

The condition that is characterized by reversible airway limitation

Patient with FEV1 = 45%, CAT score of 10, with one hospitalization due to a COPD exacerbation in the last 12 months

This relatively new oral agent for COPD may be first considered as add-on therapy in Patient Group C

This is the best counseling tip for patients on inhaled corticosteroids to avoid oral thrush

The condition that is considered to be more progressive in onset

Patient with FEV1 = 83%, CAT score of 7, with no exacerbations over the last 12 months

The vaccine that should be given in patients older than age 65 with COPD

This is the goal serum concentration for theophylline.

The condition associated with a productive cough

Patient with FEV1=25%, mMRC grade 3, with 5 exacerbations over the past year

This is the main difference in treatment of COPD versus treatment of asthma

The class of medication used in COPD that can cause dry mouth.

The condition often related to allergies

Patient with FEV1=39%, mMRC grade 1, with 1 hospitalization associated with a COPD exacerbation

This is a benefit of using a long-acting anticholinergic over using currently prescribed long-acting beta-2 agonists.

The comorbid condition in which roflumilast should be used in caution